塞特拉林通过调节TRPV1通道来缓解慢性前列腺炎
Yongfeng Lao1,2, Yanan Bai1,2, Xin Guan1,2
1Second Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Journal of inflammation research
|July 9, 2024
概括
塞特拉林通过向TRPV1通道,在老鼠模型中减轻疼痛和改善症状来证明慢性前列腺炎 (CP) 的抗炎作用. 这表明塞特拉林可能是CP的有价值的补充治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 分子生物学分子生物学
背景情况:
- 慢性前列腺炎 (CP) 是一种不清楚治疗机制的疾病.
- 塞特拉林广泛用于CP,但其潜在机制需要阐明.
研究的目的:
- 探索塞特拉林在治疗慢性前列腺炎 (CP) 的分子机制.
- 研究TRPV1通道在塞特拉林对CP的治疗作用中的作用.
主要方法:
- 网络药理学确定了关键目标,包括TRPV1.1.
- 实验室 (RWPE-1细胞) 和体内 (EAP小鼠) 模型被用于评估塞特拉林的作用.
- 试验包括细胞增殖,细胞亡,ROS和度检测,疼痛反应和组织病理学.
主要成果:
- 塞特拉林抑制了LPS诱导细胞的增殖,减少了ROS,并促进了LPS诱导细胞的亡,与TRPV1直接结合得到证实.
- 在EAP小鼠中,塞特拉林治疗减少了疼痛,抑郁症状和前列腺炎症,降低了TRPV1的表达.
- TRPV1的激活逆转了塞特拉林的作用,证实了TRPV1的核心作用.
结论:
- 塞特拉林通过调节TRPV1通道,在CP模型中表现出抗炎作用.
- 塞特拉林可以作为慢性前列腺炎的补充性抗炎剂.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
244
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
244
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
358
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
358
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
166
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
166
Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215
G-protein Coupled Receptors
117.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
117.9K
Antiasthma Drugs: Leukotriene Modifiers
269
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
269


